SSRIS and SNRIs: Broad spectrum of efficacy beyond major depression

Journal of Clinical Psychiatry

Volumn 60, Issue SUPPL. 4, 1999, Pages 33-39

  Gorman, Jack M ^a   Kent, Justine M ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUSPIRONE; CITALOPRAM; CLOMIPRAMINE; CLONAZEPAM; DESIPRAMINE; FENFLURAMINE; FLUOXETINE; FLUVOXAMINE; FLUVOXAMINE MALEATE; IMIPRAMINE; NEFAZODONE; NORADRENALIN UPTAKE INHIBITOR; PAROXETINE; PHENELZINE; PIMOZIDE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; UNCLASSIFIED DRUG; VENLAFAXINE;

AGGRESSION; ANXIETY NEUROSIS; BULIMIA; CLINICAL TRIAL; DEPRESSION; DRUG EFFICACY; DYSTHYMIA; HUMAN; MOOD; NORADRENERGIC SYSTEM; OBSESSION; PAIN; PANIC; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; REVIEW; SEROTONINERGIC SYSTEM; SEXUAL BEHAVIOR; SOCIAL PHOBIA;

EID: 0033032001     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Aston-Jones G, Akaoka H, Charlety P, et al. Serotonin selectively attenuates glutamate-evoked activation of noradrenergic locus coeruleus neurons. J Neurosci 1991;11:760-769
2. Hyman SE, Nestler ES. Initiation and adaptation: a paradigm for understanding psychotropic drug action. Am J Psychiatry 1996;153:151-162
3. Black DW, Wesner R, Bowers W, et al. A comparison of fluvoxamine, cognitive therapy, and placebo in the treatment of panic disorder. Arch Gen Psychiatry 1993;50:44-50
4. Oehrberg S, Christiansen PE, Behnke K, et al. Paroxetine in the treatment of panic disorder: a randomised, double-blind, placebo-controlled study. Br J Psychiatry 1995;167:374-379
5. Ballenger JC, Wheadon DE, Steiner M, et al. Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder. Am J Psychiatry 1998;155:36-42
6. Boyer W. Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: a meta-analysis. Int Clin Psychopharmacol 1995;10:45-49
7. Wolkow R, Apter J, Clayton A, et al. Double-blind flexible dose study of sertra-line and placebo in patients with panic disorder. Presented at the 20th Annual Meeting of the Collegium Internationale Neuropsychopharmacologicum: June 23-27, 1996; Melbourne, Australia
8. Lydiard RB, Pollack MH, Judge R, et al. Fluoxetine in panic disorder: a placebo-controlled study. Presented at the 10th Congress of the European College of Neuropsychopharmacology; September 1997; Venice, Italy
9. Coplan JD, Papp LA, Pine D, et al. Clinical improvement with fluoxetine therapy and noradrenergic function in patients with panic disorder. Arch Gen Psychiatry 1997;54:643-648
10. Geracioti TD Jr. Venlafaxine treatment of panic disorder: a case series. J Clin Psychiatry 1995;56:408-410
11. Papp LA, Sinha S, Coplan JD, et al. Low dose venlafaxine treatment in panic disorder Psychopharmacol Bull 1998;134:207-209
12. Rocca P, Fonzo V, Scotta M, et al. Paroxetine efficacy in the treatment of generalized anxiety disorder. Acta Psychiatr Scand 1997;95:440-450
13. Johnson MR, Emmanuel N, Crawford M, et al. Treatment of generalized anxiety disorder with venlafaxine: a series of 11 cases [letter]. J Clin Psychopharmacol 1998;18:418-419
14. Aguiar LM, Haskins T, Rudolph RL, et al. Double-blind placebo-controlled study of once-daily venlafaxine extended release in outpatients with GAD. In: New Research Program and Abstracts of the Annual Meeting of the American Psychiatric Association; June 3, 1998; Toronto. Canada. NR643:241
15. Entsuah R, Derivan AT, Haskins T, et al. Double-blind placebo-controlled study of once daily venlafaxine extended release and buspirone. In: New Research Program and Abstracts of the Annual Meeting of the American Psychiatric Association; June 3, 1998; Toronto, Canada. NR644:241
16. Murphy TK, Goodman WK, Fudge MW, et al. B lymphocyte antigen D8/17: a peripheral marker for childhood-onset obsessive-compulsive disorder and Tourette's syndrome? Am J Psychiatry 1997;154:402-407
17. Clomipramine Collaborative Study Group. Clomipramine in the treatment of patients with obsessive-compulsive disorder. Arch Gen Psychiatry 1991;48: 730-738
18. Pigott TA, Pato MT, Bernstein SE, et al. Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder: behavioral and biological results. Arch Gen Psychiatry 1990;47:926-932
19. Zohar J, Judge R. Paroxetine versus clomipramine in the treatment of obsessive-compulsive disorder. OCD Paroxetine Study Investigators. Br J Psychiatry 1996;169:468-474
20. Pato MT, Zohar-Kadouch R, Zohar J, et al. Return of symptoms after discontinuation of clomipramine in patients with obsessive compulsive disorder. Am J Psychiatry 1988;145:1521-1525
21. Davidson JR, Potts N, Richichi E, et al. Treatment of social phobia with clonazepam and placebo. J Clin Psychopharmacol 1993;13:423-428
22. Liebowitz MR, Schneier F, Campeas R, et al. Phenelzine vs atenolol in social phobia: a placebo controlled comparison. Arch Gen Psychiatry 1992; 39:290-300
23. van Vliet IM, den Boer JA, Westenberg HGM. Psychopharmacological treatment of social phobia: a double-blind placebo controlled study with fluvoxamine. Psychopharmacology (Berl) 1994;115:128-134
24. Katzelnick DJ, Kobak KA, Greist JH, et al. Sertraline for social phobia: a double-blind, placebo-controlled crossover study. Am J Psychiatry 1995;152: 1368-1371
25. Schneier FR, Chin SJ, Hollander E, et al. Fluoxetine for the treatment of social phobia. J Clin Psychopharmacol 1992;12:62-64
26. Stein M. An update on social phobia. Presented at the U.S. Psychiatric and Mental Health Congress; November 1997; Orlando, Fla
27. Kelsey JE. Venlafaxine in social phobia. Psychopharmacol Bull 1995; 31:767-771
28. Nagy LM, Morgan CA, Southwick SM, et al. Open prospective trial of fluoxetine for posttraumatic stress disorder. J Clin Psychopharmacol 1993;13: 107-113
29. Kline NA, Bow BM, Brown SA, et al. Sertraline efficacy in depressed combat veterans with post-traumatic stress disorder [letter]. Am J Psychiatry 1994;151:621
30. Marmar CR, Schoenfeld F, Weiss DS, et al. Open trial of fluvoxamine treatment for combat-related posttraumatic stress disorder. J Clin Psychiatry 1996; 57(suppl 8):66-70
31. van der Kolk BA, Dreyfuss D, Michaels M, et al. Fluoxetine in posttraumatic stress disorder. J Clin Psychiatry 1994;55:517-522
32. Hellerstein DJ, Yanowitch P, Rosenthal J, et al. A randomized double-blind study of fluoxetine versus placebo in the treatment of dysthymia. Am J Psychiatry 1993;150:1169-1175
33. Thase ME, Fava M, Halbreich U, et al. A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia. Arch Gen Psychiatry 1996;53:777-784
34. Goldstein DJ, Wilson MG, Thompson VL, et al. Long-term fluoxetine treatment of bulimia nervosa. Br J Psychiatry 1995;166:660-666
35. Walsh BT, Wilson GT, Loeb KL, et al. Medication and psychotherapy in the treatment of bulimia nervosa. Am J Psychiatry 1997;154:523-531